SCHEMBL3881653

SCHEMBL3881653

CCn1ccc2cc(-c3cc(CCC(=O)O)ccc3OCC3CCCC3)ccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.43
THRB P10828 1/20 0.43
FFAR4 Q5NUL3 6/20 0.42
S1PR1 P21453 1/20 0.42
PPARG P37231 1/20 0.42
NR1H2 P55055 1/20 0.42
PPARD Q03181 1/20 0.42
PPARA Q07869 1/20 0.42
NR1H3 Q13133 1/20 0.42
FFAR1 O14842 1/20 0.37
TP53 P04637 1/20 0.37
MDM2 Q00987 1/20 0.37
FAAH O00519 1/20 0.36
RXRA P19793 1/20 0.36
PTGDR2 Q9Y5Y4 2/20 0.36
C5AR1 P21730 1/20 0.35
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3883330 0.93 FFAR4 (0.45) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3881703 0.92 THRA (0.44) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3882068 0.91 FFAR4 (0.47) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3683810 0.90 FFAR4 (0.47) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3884556 0.89 THRA (0.44) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL3882968 0.88 THRA (0.46) THRATHRBFFAR4S1PR1FFAR1
SCHEMBL3883490 0.87 FFAR4 (0.44) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3883706 0.87 THRA (0.42) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3882214 0.86 FFAR4 (0.44) THRATHRBFFAR4S1PR1PPARG
SCHEMBL3881230 0.86 THRA (0.44) THRATHRBFFAR4S1PR1FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP claimed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US claimed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP claimed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US claimed
EP-1477472-B1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF ASAHI KASEI PHARMA CORP (JP) 2009-01-14 EP disclosed
US-6867320-B2 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2005-03-15 US disclosed
EP-1477472-A1 SUBSTITUTED PHENYLALKANOIC ACID DERIVATIVE AND USE THEREOF Asahi Kasei Pharma Corporation (JP) 2004-11-17 EP disclosed
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof ASAHI KASEI PHARMA CORPORATION (JP) 2004-03-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044258-A1 Substituted phenylalkanoic acid derivatives and use thereof PTGER1, CYSLTR1, PTGS1 THRA 1720/4885THRB 3187/4885FFAR4 115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.